Routine FDA testing found patulin above safety limits in Wholesome Pantry jars sold at ShopRite and four other chains ...
The FDA approved Bravnetsa as the first radioligand therapy through the Abbreviated New Drug Application pathway, offering a bioequivalent alternative to Lutathera for adult patients with ...
Lyrfigtu (lirafugratinib) is approved for previously treated, unresectable, or metastatic FGFR2-altered cholangiocarcinoma based on data from the ReFocus trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results